GlaxoSmithKline Files for Approval of Three Drugs
December 02 2016 - 9:56AM
Dow Jones News
LONDON--GlaxoSmithKline PLC (GSK.LN) said Friday it has filed
for approval with the European Medicines Agency for three types of
medicine aimed at patients with a chronic obstructive pulmonary
disease.
Shares at 1425 GMT down 6.50 pence, or 0.5%, at 1,461.50 pence
valuing the company at GBP71.27 billion.
Write to Olga Cotaga at olga.cotaga@wsj.com, Twitter
@OlgaCotaga
(END) Dow Jones Newswires
December 02, 2016 09:41 ET (14:41 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Sep 2023 to Sep 2024